Chapter 4. Central Nervous System
MHRA DSU: Antidepressants: risk of fractures, May 2010 Subsection 4.3.1. Tricyclic and related antidepressants Tricyclic antidepressants (TCAs) are not usually recommended as a first-line treatment for depression because they are associated with a greater risk of side effects than SSRIs or SNRIs and are generally more toxic in overdose
Download Chapter 4. Central Nervous System
Information
Domain:
Source:
Link to this page:
Documents from same domain
Rufinamide (Inovelon® ) in the treatment of seizures ...
gmmmg.nhs.ukNOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES Date of original recommendation: 22nd June 2010 Date Re-reviewed: 21st October 2014 Rufinamide (Inovelon® ) in the treatment of seizures
FreeStyle Libre Flash Glucose Monitoring System.
gmmmg.nhs.ukNOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES November 2017 FreeStyle Libre Flash Glucose Monitoring System. The Formulary and Managed Entry Subgroup discussed the above at its
NTS recommendation Brimonidine gel for acne …
gmmmg.nhs.ukNOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES 17th June 2014 Brimonidine (Mirvaso® ) gel for the treatment of acne rosacea erythema. The New Therapies Subgroup (NTS) discussed the above drug at a
Tapentadol (Palexia®) prolonged and immediate …
gmmmg.nhs.ukNovember 2015 Tapentadol (Palexia®) prolonged and immediate release tablets for the treatment of acute and chronic severe pain. The New Therapies Subgroup of the Greater Manchester Medicines
Hydrocortisone modified release tablet …
gmmmg.nhs.ukNOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES 17th April 2014 Hydrocortisone modified release tablet (Plenadren®) for the treatment of adrenal …
Low Strength Antipsychotic Prescribing in Dementia: A GP ...
gmmmg.nhs.ukGMMMG – championing the appropriate use of medicines across Greater Manchester PAGE | 4 AIM AIM To aid the primary care review of low strength antipsychotic prescribing in dementia patients.
GMMMG COPD Formulary Inhaler Options September 2018 ...
gmmmg.nhs.ukGMMMG COPD Formulary Inhaler Options – September 2018 Produced by Regional Drug and Therapeutics Centre (RDTC) for the GMMMG. September 2018 BNF 3.1.2 – Antimuscarinic bronchodilators (LAMA) 1st choice Alternatives Tiotropium Aclidinium Glycopyrronium Umeclidinium
Non-pharmacological management for ALL patients
gmmmg.nhs.uk6 Treatment of new COPD patients FEV 1 Spirometry (measuring FEV 1 and FVC) is needed to make the diagnosis of COPD. FEV 1 can be used to measure worsening or improvement in patients.
Cost Comparison Charts - GMMMG
gmmmg.nhs.ukRegional Drug and Therapeutics Centre Cost comparison charts 2 Jul 2019
Management of Vitamin D Deficiency, Insufficiency and ...
gmmmg.nhs.ukPatient group Advice ... (for example, they have osteomalacia).2 Routine screening of high risk groups is not indicated. For convenience, paediatric reference ranges and definitions of deficiency used here are the same as for adults as per the NOS guidance.3 Any child who is suspected to be hypocalcaemic secondary
Related documents
Antidepressant treatment in adults
pathways.nice.org.uksignificant side effects . or . switching to another antidepressant if there are side effects or if the person prefers. If there is some improvement by 4 weeks, continue treatment for another 2 to 4 weeks. Consider switching antidepressants if: response is still not adequate . or . there are side effects . or . the person prefers to change drug.